The price trend for Biotricity Inc. (BTCY) has been bearish lately and the stock has lost 15.3% over the past two weeks. However, the formation of a hammer chart pattern in its last trading session indicates that the stock could witness a trend reversal soon, as bulls might have gained significant control over the price to help it find support.The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor ...

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks and waiting long for them to recover. They believe instead that one could make far more money in lesser time by "buying high and selling higher."Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves a ...

Biotricity Inc. (BTCY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Si ...

Biotricity, Inc. (NASDAQ:BTCY) Q3 2024 Earnings Call Transcript February 21, 2024 4:30 PM ET Company Participants Debra Chen - IR Waqaas Al-Siddiq - Founder and CEO John Ayanoglou - CFO Conference Call Participants Ben Haynor - Alliance Global Partners Michael Davin - H.C. Wainwright Operator Good afternoon, I welcome to Biotricity Third Quarter Fiscal 2024 Financial Results and Business Update Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to D ...

Biotricity Inc. (BTCY) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 17.07%. A quarter ago, it was expected that this company would post a loss of $0.34 per share when it actually produced a loss of $0.44, delivering a surprise of -29.41%.Over the last four quarters, the company has surpass ...

● Fair value of derivative liabilities In determining the fair values of the derivative liabilities from the conversion and redemption features, the Company used MonteCarlo and lattice models with the following assumptions: dividend yields, volatility, risk-free rate and the remaining expected life. Changes in those assumptions and inputs could in turn impact the fair value of the derivative liabilities and can have a material impact on the reported loss and comprehensive loss for the applicable reporting p ...

Company Participants Waqaas Al-Siddiq - Founder and CEO Conference Call Participants Operator And at this time, I would like to turn the conference over to Debra Chen with Investor Relations. Please go ahead, ma'am. Good afternoon, everyone, and welcome to Biotricity's second quarter fiscal 2024 earnings conference call. As a reminder, Biotricity's second quarter 2024 fiscal year ended September 30, 2023. So all figures presented for this period will reflect that end date. Earlier, Biotricity issued its fis ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share BTCY The NASDAQ Stock Market LLC Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the period from ______________ ...

Biotricity (NASDAQ:BTCY) Q1 2024 Earnings Conference Call August 15, 2023 4:30 PM ET Debra Chen – Investor Relations Conference Call Participants Operator Debra Chen Before beginning the companyÂ's formal remarks, IÂ'd like to remind listeners that todayÂ's discussion may contains forward-looking statements that reflect managementÂ's current views with respect to future events. Any such statements are subject to risks and uncertainties that can cause actual results to differ materially from those projected ...

Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the period from ______________ to_______________ Commission file number: 000-40761 BIOTRICITY INC. (Exact name of registrant as specified in its charter) Nevada 30-0983531 State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 203 Redwood Shores Parkway, Suite 600 Redwood City, C ...